Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), today announced CE Certification of its enFuse on-body ...
Morning Overview on MSN
A new wearable patch can read your blood sugar right through your skin — no needle prick required — and it’s heading toward store shelves
For the roughly 38 million Americans living with diabetes, checking blood sugar usually means one thing: breaking the skin.
Obesity weight loss pills could be covered by Louisiana Medicaid as a bill makes its way through the state legislature.
Obesity is a chronic disease. This statement is clearly at the heart of the answer to this question. When you look at the data in the STEP 1 trial extension, semaglutide (Wegovy, Novo Nordisk) works ...
Twenty-three abstracts will highlight the versatility and strength of Genmab’s portfolio and pipeline, including data from the comprehensive epcoritamab development program, including 4 oral ...
The cutaneous T-cell lymphoma clinical trial analysis report delivers important insights into ongoing research of 30+ ...
The FDA has approved Immgolis and Immgolis Intri (golimumab-sldi), the first interchangeable biosimilars for Simponi and Simponi Aria to treat RA and UC.
The pulmonary arterial hypertension clinical trial analysis report delivers important insights into ongoing research of 55+ ...
Compared to patients adherent to monthly injectable buprenorphine, patients on other MOUD (adherent and non-adherent) were 3.5 to 8.1x more ...
Kesimpta (ofatumumab) is a subcutaneous injection for adults with relapsing forms of multiple sclerosis. Follow the instructions here to self-inject safely. It’s important to switch injection sites ...
The drug ivermectin is one example. It’s gotten a lot of attention in recent years, but is not approved to treat any cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results